SC-102

· Tianjin ConjuStar Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC-102, covering 2025-07-29 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of SC-102 in Patients With Advanced Solid Tumors [Phase 1]